Intravenous Immunoglobulin (IVIg) Market Futuristic Pharmaceuticals Industry [2019-2023] with Size, Share, Growth, Trend, Outlook Forecast to 2023

MRFR Offers A Thorough Analysis Of Intravenous Immunoglobulin (Ivig) Market Provides The Latest Information On The Present And The Future Industry Trends, Allowing The Readers To Identify The Products And Services, Hence Driving The Revenue Growth And Profitability.

PUNE, India - July 16, 2019 /MarketersMedia/ —

Market overview :

MRFR asserts that the global intravenous immunoglobulin market growing further will Reach USD 8337.2 MN By 2023, Registering Approximately 5.9% CAGR From 2017 To 2023. 

Intravenous Immunoglobulin (IVIg), a compound comprising of immune proteins (globulins) is administered into the bloodstream to treat patients with inefficient or damaged immune systems. IVIg provides the required antibodies by the human body to fight out the immune deficiency, and the ensuing infectious attacks.

Considering the kind of the growth the market perceives currently; Market Research Future (MRFR) has recently published a study report giving out the complete market forecast up to 2023. In its analysis, Immunodeficiency disorder could be a hereditary issue (Primary disorders), or caused due to the exposure to infections, mainly through bodily fluids, along with the cancer drugs and chemotherapy, aging is one of the key risk factors too that could put someone at higher risk of a damaged immune system.

People nowadays are increasingly adopting heady & unhealthy lifestyles which mirror the prevalence of damaged immune system. Factors such as immense stress, lack of good quality sleep, inadequate & improper diet and sedentary lifestyle are fuelling the prevalence of immunodeficiency disorder and therefore, predominantly driving the growth of the market. 

Fill Out Details To Receive FREE Sample Here: @ https://www.marketresearchfuture.com/sample_request/3137
Major Players:

Key players leading the global IVIg market include Baxter (US), BDI Pharma (US), Abeona Therapeutics (US), China Biologic Products, Inc. (China), Grifols Inc. (Spain), Biotest AG. (Germany), CSL Behring (US), Octapharma (Switzerland), Kedrion S.p.A (US), and Shire (Republic of Ireland) among others.

Industry, Innovation & Related News

March 28, 2019 --- CSL Behring (the US), a leading global biotherapeutics and biopharmaceutical company, manufacturing plasma-derived and recombinant therapeutic products announced the receiving of an approval from Japan's Ministry of Health, Labour and Welfare has for two of its immunoglobulin therapies - named Hizentra and Privigen for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy.

Out of these, Hizentra which was previously approved for the treatment of primary immunodeficiency (PI) is now Japan's first and only subcutaneous immunoglobulin (SCIG) treatment approved for maintenance therapy to treat CIDP.  Privigen, an intravenous immunoglobulin (IVIG), is now approved for both acute and maintenance treatment of CIDP in Japan.  

Global IVIg Market – Segments

For ease of understanding, the market is segmented into three key dynamics: -

By Types                 : IgA, (IgA1 & A2), IgD, IgE, IgG, and IgM.

By Applications   : Chronic Inflammatory Demyelinating, Hypogammaglobulinemia Multifocal Motor Neuropathy, Immunodeficiency Diseases, CVID (common variable immunodeficiency), SCI (severe combined immunodeficiency), Primary Humoral Immunodeficiency, Unknown (idiopathic) Immunodeficiency diseases, Myasthenia Gravis, Guillain-Barre syndrome, MFS (Miller Fisher Syndrome), AMAN (Acute motor axonal neuropathy) and AMSAN (acute motor-sensory axonal neuropathy), Kawasaki disease, and ITP among others.

By Regions: North America, Asia Pacific, Europe, and the Rest-of-the-World.

The augmenting demand for alternate immunoglobulin replacement therapies, increasing R&D funding, rapidly developing healthcare infrastructure and increasing healthcare expenditures are major driving forces for the market growth.  Technological advancements transpired in medical science, are fostering the growth of the market exponentially, bringing up new treatment procedures, & medications in the field of IVIg.

Additionally, factors such as growing population and geriatric populace worldwide are fostering market growth. Rapidly developing economy worldwide is providing impetus to the market growth, enabling access to the quality life & improved healthcare. Substantial investments made in the development of IVIg, by the key market players are paying off well, driving the growth of the market.

On the flip side, factors such as low awareness among people about the availability of treatment, the high cost of IVIg management along with the skepticism towards the advancement & efficacies of these treatments among the patients are likely to impede the growth of the Intravenous Immunoglobulin market.

Global Intravenous Immunoglobulin Market – Regional Analysis

The North American region, heading with the presence of a large number of key players and a well-established healthcare sector accounts for the leading market in the global IVIg market.

The US market backed by the high expenditure on healthcare accounts for the largest contributor to the growth of the regional market. Moreover, the increasing prevalence of immunodeficiency disorder and rising demand for treatment measures provide impetus to market growth.

BROWSE COMPLETE 100 PAGES PREMIUM RESEARCH REPORT ENABLED WITH 40+ RESPECTIVE TABLES AND FIGURES @ https://www.marketresearchfuture.com/reports/intravenous-immunoglobulin-market-3137

The intravenous immunoglobulin market in the European region accounts for the second-largest market, globally.

The IVIg market in Europe is fostered by the high per capita income and robust healthcare penetration in the region. The strong market growth in countries like Germany & France drives the regional market growth, large scale. Moreover, factors such as the increasing investments in healthcare and the rising number of patients with immune system diseases are helping the market to create a larger revenue pocket.

The Asia Pacific intravenous immunoglobulin market is expected to perceive an exponential growth. Factors such as the vast population and the burgeoning medical treatment market, especially in India & China, drive the growth of the regional market. Vietnam, Thailand, and Malaysia among the other South East Asian countries are projected to contribute significantly to the market growth in the region. With the growing Medical Tourism markets in India & Malaysia, the APAC region will register a significant CAGR during the review period.

Global Intravenous Immunoglobulin Market – Competitive Landscape

Fiercely competitive, the global IVIg market appears to be fragmented due to the presence of several large and small players. These players acquire small yet promising companies to expand their reach in the emerging markets, focusing on improving their market performance. The acquisition of local manufactures by multinational companies makes the market structure look dynamic. Strategies such as product innovations and technologies are creating strong investment opportunities for the players.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact Info:
Name: Abhishek Sawant
Email: Send Email
Organization: Market Research Future
Address: Contact:, , Market Research Future, , Office No. 528, Amanora Chambers, , Magarpatta Road, Hadapsar,, , Pune - 411028, , Maharashtra, India, , +1 646 845 9312, , Email: sales@marketresearchfuture.com
Phone: 646845931
Website: https://www.marketresearchfuture.com

Source URL: https://marketersmedia.com/intravenous-immunoglobulin-ivig-market-futuristic-pharmaceuticals-industry-2019-2023-with-size-share-growth-trend-outlook-forecast-to-2023/88897013

Source: MarketersMedia

Release ID: 88897013

More News From Morning Dispatcher

Saudi energy minister: Saudi Aramco's public offering 'soon'

Dec 16, 2019

RIYADH, Saudi Arabia — A planned stock offering of a small part of state-run oil giant Saudi Aramco "will come soon" and only at the direction of Saudi Arabia's crown prince, the kingdom's energy minister said Wednesday, further underlining the power of the 34-year-old royal. The minister, Prince Abdulaziz bin Salman, did not address reports that Aramco shares will begin to be traded on Riyadh's Tadawul stock market in December, but like Aramco itself, he did not dispute the initial public offering dates reported the day before by a Saudi-owned satellite news channel. However, there have been repeated delays to...

The Latest: Iraqi officials: 2 protesters killed in Baghdad

Dec 16, 2019

BAGHDAD — The Latest on anti-government protests in Iraq (all times local): 3 p.m. Iraqi officials say two protesters have been killed and at least 105 have been wounded in clashes with security forces in central Baghdad's Tahrir Square. At least 72 protesters have been killed since nationwide anti-government protests resumed on Friday, after an earlier wave of demonstrations this month saw 149 killed. The protesters are demanding the resignation of the government, which they blame for corruption, economic stagnation and poor services. Iraqi security and medical officials confirmed the latest casualties on Monday, speaking on condition of anonymity because...

Taliban say new intra-Afghan peace talks to be held in China

Dec 16, 2019

ISLAMABAD — A fresh round of intra-Afghan peace talks will be held in China next week, Taliban spokesman Suhail Shaheen said Tuesday, raising hopes for renewed negotiations, even as violence surges in Afghanistan's 18-year war. The talks planned for Oct. 28 and 29 will be the first meeting between Taliban and prominent Afghans from Kabul since a July round of talks held in Doha, the capital of the Middle Eastern State of Qatar, where the Taliban maintain a political office. On Monday, the U.S. State Department said its peace envoy, Zalmay Khalilzad, started a fresh round of talks with European,...

2 Indian states hold elections Modi's party expected to win

Dec 16, 2019

NEW DELHI — Voters cast ballots Monday in two Indian states where Prime Minister Narendra Modi's Hindu nationalist party is seeking a second consecutive term. The Bharatiya Janata Party is expected to win the elections in Maharashtra in the west and Haryana in the north after its dominant victory in national elections earlier this year. Modi took to Twitter to urge voters to participate in large numbers and exercise their right to vote and "enrich the festival of democracy." The BJP's high-voltage election campaigning aggressively raised the nationalism plank by focusing on the government's scrapping of disputed Kashmir's special status...

Turkish-backed forces, Kurds clash despite Syria cease-fire

Dec 16, 2019

AKCAKALE, Turkey — Turkish-backed Syrian fighters clashed with Kurdish-led forces in several parts of northeastern Syria on Saturday, with some crossing the border from Turkey to attack a village, a war monitor said. Both sides blamed each other for fighting that has rattled the U.S.-brokered cease-fire. Nearly two days into the five-day halt in fighting, the two sides were still trading fire around the key border town of Ras al-Ayn. There has also been no sign of a withdrawal of Kurdish-led forces from positions along the Syrian-Turkish border as called for under the agreement, reached between Turkey and the United...

About Us

Get all the up-to-date breaking news about politics, business, entertainment, sports, lifestyles, weather, traffic, and local news in a seamless digital environment only in Morning Dispatcher.

Contact us: sales[at]morningdispatcher.com

Subscribe Now!

Quick Links

HomePress